267 related articles for article (PubMed ID: 27571579)
21. Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms.
Kota DJ; DiCarlo B; Hetz RA; Smith P; Cox CS; Olson SD
Sci Rep; 2014 Apr; 4():4565. PubMed ID: 24691433
[TBL] [Abstract][Full Text] [Related]
22. The expression and role of miR-301a in human umbilical cord-derived mesenchymal stromal cells.
Ma F; Chen D; Chi Y; Chen F; Li X; Han Z
Cytotherapy; 2013 Dec; 15(12):1511-6. PubMed ID: 24035358
[TBL] [Abstract][Full Text] [Related]
23. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity.
Lei J; Wang Z; Hui D; Yu W; Zhou D; Xia W; Chen C; Zhang Q; Wang Z; Zhang Q; Xiang AP
Cell Immunol; 2011; 271(1):147-56. PubMed ID: 21757189
[TBL] [Abstract][Full Text] [Related]
24. In patients with chronic aplastic anemia, bone marrow-derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway.
Li H; Wang L; Pang Y; Jiang Z; Liu Z; Xiao H; Chen H; Ge X; Lan H; Xiao Y
Sci Rep; 2017 Feb; 7():42488. PubMed ID: 28195151
[TBL] [Abstract][Full Text] [Related]
25. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.
Lim JY; Im KI; Lee ES; Kim N; Nam YS; Jeon YW; Cho SG
Sci Rep; 2016 Jun; 6():26851. PubMed ID: 27246365
[TBL] [Abstract][Full Text] [Related]
26. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
[TBL] [Abstract][Full Text] [Related]
28. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
Romieu-Mourez R; François M; Boivin MN; Bouchentouf M; Spaner DE; Galipeau J
J Immunol; 2009 Jun; 182(12):7963-73. PubMed ID: 19494321
[TBL] [Abstract][Full Text] [Related]
29. The effect of TLR3 priming conditions on MSC immunosuppressive properties.
Tolstova T; Dotsenko E; Kozhin P; Novikova S; Zgoda V; Rusanov A; Luzgina N
Stem Cell Res Ther; 2023 Nov; 14(1):344. PubMed ID: 38031182
[TBL] [Abstract][Full Text] [Related]
30. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
32. Priming TLR3 and TLR4 in human adipose- and olfactory mucosa-derived mesenchymal stromal cells and comparison of their cytokine secretions.
Jafari M; Asghari A; Delbandi AA; Jalessi M; Jazayeri MH; Samarei R; Tajik N
Cytotechnology; 2020 Feb; 72(1):57-68. PubMed ID: 31898754
[TBL] [Abstract][Full Text] [Related]
33. The Upregulation of Toll-Like Receptor 3 via Autocrine IFN-β Signaling Drives the Senescence of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Through JAK1.
Lee HJ; Choi B; Kim Y; Lee SE; Jin HJ; Lee HS; Chang EJ; Kim SW
Front Immunol; 2019; 10():1659. PubMed ID: 31396213
[TBL] [Abstract][Full Text] [Related]
34. Crosstalk between Toll-like receptor 3 and Notch signaling contributes to CD14
Hao J; Li P; Tian Y; Wang Y; Li S; Wang L; Li S
Int Immunopharmacol; 2018 Jul; 60():26-33. PubMed ID: 29702280
[TBL] [Abstract][Full Text] [Related]
35. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells.
Cahill EF; Tobin LM; Carty F; Mahon BP; English K
Stem Cell Res Ther; 2015 Mar; 6(1):19. PubMed ID: 25890330
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.
Tessier L; Bienzle D; Williams LB; Koch TG
PLoS One; 2015; 10(4):e0122954. PubMed ID: 25902064
[TBL] [Abstract][Full Text] [Related]
37. TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling.
He X; Wang H; Jin T; Xu Y; Mei L; Yang J
PLoS One; 2016; 11(3):e0149876. PubMed ID: 26930594
[TBL] [Abstract][Full Text] [Related]
38. Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases.
Li CL; Leng Y; Zhao B; Gao C; Du FF; Jin N; Lian QZ; Xu SY; Yan GL; Xia JJ; Zhuang GH; Fu QL; Qi ZQ
Stem Cells; 2017 Jul; 35(7):1719-1732. PubMed ID: 28520232
[TBL] [Abstract][Full Text] [Related]
39. TLR3-/4-Priming Differentially Promotes Ca(2+) Signaling and Cytokine Expression and Ca(2+)-Dependently Augments Cytokine Release in hMSCs.
Park KS; Kim SH; Das A; Yang SN; Jung KH; Kim MK; Berggren PO; Lee Y; Chai JC; Kim HJ; Chai YG
Sci Rep; 2016 Mar; 6():23103. PubMed ID: 26980664
[TBL] [Abstract][Full Text] [Related]
40. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.
Gieseke F; Kruchen A; Tzaribachev N; Bentzien F; Dominici M; Müller I
Eur J Immunol; 2013 Oct; 43(10):2741-9. PubMed ID: 23817958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
